? Cancer Prevention and Control Program The UNC Lineberger Cancer Prevention and Control Program focuses on the development, evaluation, and dissemination of evidence-based interventions and policy approaches to improve cancer outcomes in North Carolina and beyond. Our program is comprised of leading scientists and clinicians with backgrounds in psychology, sociology, health behavior, health services research, nutrition, exercise physiology, statistics, nursing and oncology all focused on improving understanding of the prevention and control of cancer. There are four broad themes in the program: (1) implementing health promotion interventions to reduce cancer risk factors and eliminate cancer health disparities; (2) developing cancer communication strategies to improve cancer outcomes; (3) improving quality of cancer care and long-term outcomes for cancer survivors; and (4) studying patterns of cancer care, screening, and prevention to inform interventions and policy initiatives that improve cancer outcomes. The program has received substantial new investment in infrastructure, research support and recruitment as befits one of three major UNC Lineberger strategic directions, ?Optimizing Cancer Outcomes in North Carolina?. Highlights of nationally recognized research by program investigators include tobacco control policy research that guides state and national policy on the sales and marketing of electronic cigarettes, and design of graphic cigarette warning labels; research on Internet and mobile interventions for diet/obesity/physical activity in adolescents and adults with a particular focus on disadvantaged populations and cancer survivors; understanding the impact of message tailoring and other health communication strategies; development of national cancer survivorship care plans; creation of unique multi-payer linked databases for cancer outcomes research; and novel patient-reported outcomes studies that inform national policy. The Program is led by Dr. Kurt Ribisl, a behavioral scientist and Dr. Ethan Basch, a medical oncologist and health services researcher. Program members are PIs of three NCI funded pre- and post-doctoral training grants. The Program adds value in terms of integrative activities and opportunities for collaboration, access to shared resources, such as the Communications for Health Applications and Interventions, Biostatistics, and Outcomes Cores, as well as space, seminars, retreats, and training and education. UNC Lineberger has benefited the Program through strong support for faculty recruitments, extensive use of shared resources, and providing developmental funds. Significant faculty recruiting supported by the Center has resulted in 22 new program members including nationally-recognized senior investigators and promising junior faculty. There are 45 program members and our program has strong collaborations between faculty from the Schools of Medicine, Public Health, Nursing, and Journalism and the College of Arts and Sciences. During the last funding period, program members have published 951 cancer-related articles (34% collaborative). In 2014, our program members held 93 grants and $31M (total cost) in annual extramural funding, including 38 grants and $13.6M (total costs) from the NCI. Program members accrued 1984 subjects to research studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-43
Application #
9614930
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Anderson, Chelsea; Smitherman, Andrew B; Nichols, Hazel B (2018) Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer 124:3037-3043
Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia et al. (2018) Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene 37:1637-1653
Curtis 2nd, Alan D; Jensen, Kara; Van Rompay, Koen K A et al. (2018) A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques. J Med Primatol 47:288-297
Williams, Lindsay A; Nichols, Hazel B; Hoadley, Katherine A et al. (2018) Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25-32
Amunugama, Ravindra; Willcox, Smaranda; Wu, R Alex et al. (2018) Replication Fork Reversal during DNA Interstrand Crosslink Repair Requires CMG Unloading. Cell Rep 23:3419-3428
Little, Michael S; Pellock, Samuel J; Walton, William G et al. (2018) Structural basis for the regulation of ?-glucuronidase expression by human gut Enterobacteriaceae. Proc Natl Acad Sci U S A 115:E152-E161
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 556:135
Dellon, Evan S; Selitsky, Sara R; Genta, Robert M et al. (2018) Gene expression-phenotype associations in adults with eosinophilic esophagitis. Dig Liver Dis 50:804-811
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Chai, Zheng; Zhang, Xintao; Rigsbee, Kelly Michelle et al. (2018) Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration. J Control Release 286:415-424

Showing the most recent 10 out of 1525 publications